Cargando…
Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification
BACKGROUND: Cholangiocarcinoma (CCA) has been categorized based on tumor location as intrahepatic (ICCA), perihilar (PCCA) or distal (DCCA), and based on the morphology of the tumor of the bile duct as mass forming (MF), periductal infiltrating (PI) or intraductal (ID). To date, there is limited evi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094526/ https://www.ncbi.nlm.nih.gov/pubmed/33941120 http://dx.doi.org/10.1186/s12885-021-08247-z |
_version_ | 1783687987499892736 |
---|---|
author | Tawarungruang, Chaiwat Khuntikeo, Narong Chamadol, Nittaya Laopaiboon, Vallop Thuanman, Jaruwan Thinkhamrop, Kavin Kelly, Matthew Thinkhamrop, Bandit |
author_facet | Tawarungruang, Chaiwat Khuntikeo, Narong Chamadol, Nittaya Laopaiboon, Vallop Thuanman, Jaruwan Thinkhamrop, Kavin Kelly, Matthew Thinkhamrop, Bandit |
author_sort | Tawarungruang, Chaiwat |
collection | PubMed |
description | BACKGROUND: Cholangiocarcinoma (CCA) has been categorized based on tumor location as intrahepatic (ICCA), perihilar (PCCA) or distal (DCCA), and based on the morphology of the tumor of the bile duct as mass forming (MF), periductal infiltrating (PI) or intraductal (ID). To date, there is limited evidence available regarding the survival of CCA among these different anatomical and morphological classifications. This study aimed to evaluate the survival rate and median survival time after curative surgery among CCA patients according to their anatomical and morphological classifications, and to determine the association between these classifications and survival. METHODS: This study included CCA patients who underwent curative surgery from the Cholangiocarcinoma Screening and Care Program (CASCAP), Northeast Thailand. The anatomical and morphological classifications were based on pathological findings after surgery. Survival rates of CCA and median survival time since the date of CCA surgery and 95% confidence intervals (CI) were calculated. Multiple cox regression was performed to evaluate factors associated with survival which were quantified by hazard ratios (HR) and their 95% CIs. RESULTS: Of the 746 CCA patients, 514 had died at the completion of the study which constituted 15,643.6 person-months of data recordings. The incidence rate was 3.3 per 100 patients per month (95% CI: 3.0–3.6), with median survival time of 17.8 months (95% CI: 15.4–20.2), and 5-year survival rate of 24.6% (95% CI: 20.7–28.6). The longest median survival time was 21.8 months (95% CI: 16.3–27.3) while the highest 5-year survival rate of 34.8% (95% CI: 23.8–46.0) occurred in the DCCA group. A combination of anatomical and morphological classifications, PCCA+ID, was associated with the longest median survival time of 40.5 months (95% CI: 17.9–63.0) and the highest 5-year survival rate of 42.6% (95% CI: 25.4–58.9). The ICCA+MF combination was associated with survival (adjusted HR: 1.45; 95% CI: 1.01–2.09; P = 0.013) compared to ICCA+ID patients. CONCLUSIONS: Among patients receiving surgical treatment, those with PCCA+ID had the highest 5-year survival rate, which was higher than in groups classified by only anatomical characteristics. Additionally, the patients with ICCA+MF tended to have unfavorable surgical outcomes. Showed the highest survival association. Therefore, further investigations into CCA imaging should focus on patients with a combination of anatomical and morphological classifications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08247-z. |
format | Online Article Text |
id | pubmed-8094526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80945262021-05-04 Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification Tawarungruang, Chaiwat Khuntikeo, Narong Chamadol, Nittaya Laopaiboon, Vallop Thuanman, Jaruwan Thinkhamrop, Kavin Kelly, Matthew Thinkhamrop, Bandit BMC Cancer Research BACKGROUND: Cholangiocarcinoma (CCA) has been categorized based on tumor location as intrahepatic (ICCA), perihilar (PCCA) or distal (DCCA), and based on the morphology of the tumor of the bile duct as mass forming (MF), periductal infiltrating (PI) or intraductal (ID). To date, there is limited evidence available regarding the survival of CCA among these different anatomical and morphological classifications. This study aimed to evaluate the survival rate and median survival time after curative surgery among CCA patients according to their anatomical and morphological classifications, and to determine the association between these classifications and survival. METHODS: This study included CCA patients who underwent curative surgery from the Cholangiocarcinoma Screening and Care Program (CASCAP), Northeast Thailand. The anatomical and morphological classifications were based on pathological findings after surgery. Survival rates of CCA and median survival time since the date of CCA surgery and 95% confidence intervals (CI) were calculated. Multiple cox regression was performed to evaluate factors associated with survival which were quantified by hazard ratios (HR) and their 95% CIs. RESULTS: Of the 746 CCA patients, 514 had died at the completion of the study which constituted 15,643.6 person-months of data recordings. The incidence rate was 3.3 per 100 patients per month (95% CI: 3.0–3.6), with median survival time of 17.8 months (95% CI: 15.4–20.2), and 5-year survival rate of 24.6% (95% CI: 20.7–28.6). The longest median survival time was 21.8 months (95% CI: 16.3–27.3) while the highest 5-year survival rate of 34.8% (95% CI: 23.8–46.0) occurred in the DCCA group. A combination of anatomical and morphological classifications, PCCA+ID, was associated with the longest median survival time of 40.5 months (95% CI: 17.9–63.0) and the highest 5-year survival rate of 42.6% (95% CI: 25.4–58.9). The ICCA+MF combination was associated with survival (adjusted HR: 1.45; 95% CI: 1.01–2.09; P = 0.013) compared to ICCA+ID patients. CONCLUSIONS: Among patients receiving surgical treatment, those with PCCA+ID had the highest 5-year survival rate, which was higher than in groups classified by only anatomical characteristics. Additionally, the patients with ICCA+MF tended to have unfavorable surgical outcomes. Showed the highest survival association. Therefore, further investigations into CCA imaging should focus on patients with a combination of anatomical and morphological classifications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08247-z. BioMed Central 2021-05-03 /pmc/articles/PMC8094526/ /pubmed/33941120 http://dx.doi.org/10.1186/s12885-021-08247-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Tawarungruang, Chaiwat Khuntikeo, Narong Chamadol, Nittaya Laopaiboon, Vallop Thuanman, Jaruwan Thinkhamrop, Kavin Kelly, Matthew Thinkhamrop, Bandit Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification |
title | Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification |
title_full | Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification |
title_fullStr | Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification |
title_full_unstemmed | Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification |
title_short | Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification |
title_sort | survival after surgery among patients with cholangiocarcinoma in northeast thailand according to anatomical and morphological classification |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094526/ https://www.ncbi.nlm.nih.gov/pubmed/33941120 http://dx.doi.org/10.1186/s12885-021-08247-z |
work_keys_str_mv | AT tawarungruangchaiwat survivalaftersurgeryamongpatientswithcholangiocarcinomainnortheastthailandaccordingtoanatomicalandmorphologicalclassification AT khuntikeonarong survivalaftersurgeryamongpatientswithcholangiocarcinomainnortheastthailandaccordingtoanatomicalandmorphologicalclassification AT chamadolnittaya survivalaftersurgeryamongpatientswithcholangiocarcinomainnortheastthailandaccordingtoanatomicalandmorphologicalclassification AT laopaiboonvallop survivalaftersurgeryamongpatientswithcholangiocarcinomainnortheastthailandaccordingtoanatomicalandmorphologicalclassification AT thuanmanjaruwan survivalaftersurgeryamongpatientswithcholangiocarcinomainnortheastthailandaccordingtoanatomicalandmorphologicalclassification AT thinkhamropkavin survivalaftersurgeryamongpatientswithcholangiocarcinomainnortheastthailandaccordingtoanatomicalandmorphologicalclassification AT kellymatthew survivalaftersurgeryamongpatientswithcholangiocarcinomainnortheastthailandaccordingtoanatomicalandmorphologicalclassification AT thinkhamropbandit survivalaftersurgeryamongpatientswithcholangiocarcinomainnortheastthailandaccordingtoanatomicalandmorphologicalclassification |